Toxys is a global leader in in vitro toxicology, developing innovative New Approach Methodologies (NAMs) for the safety assessment of pharmaceuticals, chemicals, cosmetics, and food-related products. The company specializes in genetic, developmental, and investigative toxicology testing, with a focus on providing mechanistic insight of test substances. With a strong commitment to scientific excellence and sustainability, Toxys is shaping the future of toxicology. The company collaborates with leading research institutions and regulatory bodies worldwide and continues to expand its global footprint through strategic partnerships and product innovation.